T1	drug 36 47	amoxicillin
T2	studyType 64 79	crossover study
T3	food 137 141	food
T4	pharmacokinetics 149 159	absorption
T5	drug 163 174	amoxicillin
T6	drug 179 189	ampicillin
T7	population 205 223	16 normal subjects
T8	studyType 229 257	double-blind crossover study
T9	frequency 289 295	single
T10	mode 296 300	oral
T11	dosage 301 307	500-mg
T14	pharmacokinetics 495 513	kinetic parameters
T15	drug 630 641	amoxicillin
T16	pharmacokinetics 642 652	absorption
T19	pharmacokinetics 735 755	area under the curve
T23	drug 879 889	Ampicillin
T24	pharmacokinetics 890 900	absorption
T25	interaction 919 928	decreased
T27	pharmacokinetics 1191 1201	absorption
T28	mode 1205 1211	orally
T29	drug 1225 1236	amoxicillin
T30	drug 52 62	ampicillin
T31	pharmacokinetics 437 457	area under the curve
T38	pharmacokinetics 1033 1053	area under the curve
T40	parameter 1106 1122	urinary recovery
T26	pharmacokinetics 16 32	Pharmacokinetics
T33	food 97 101	food
T42	pharmacokinetics 358 386	one-compartment linear model
T43	mealTime 1264 1275	asted state
T12	pharmacokinetics 392 414	first-order absorption
T13	pharmacokinetics 419 435	absorption delay
T32	meal 601 608	fasting
T44	meal 616 626	nonfasting
T45	interaction 588 597	no effect
T17	pharmacokinetics 670 686	peak serum level
T18	value 710 720	8.8 mug/ml
T46	meal 722 732	nonfasting
T48	meal 701 708	fasting
T47	value 689 699	8.9 mug/ml
T20	meal 780 787	fasting
T49	meal 812 822	nonfasting
T50	value 789 800	22.2 mug/ml
T51	value 757 767	26.9 mug/m
T34	meal 852 859	fasting
T52	meal 866 876	nonfasting
T53	value 847 850	47%
T54	value 861 864	44%
T36	meal 1000 1007	fasting
T55	meal 1021 1031	nonfasting
T56	value 1009 1019	4.0 mug/ml
T57	value 988 998	5.4 mug/ml
T58	pharmacokinetics 976 987	peak level:
T39	value 1055 1068	17.4 h.mug/ml
T41	meal 1070 1077	fasting
T59	value 1079 1092	12.0 h.mug/ml
T60	meal 1094 1104	nonfasting
T61	meal 1143 1153	nonfasting
T62	meal 1129 1136	fasting
T63	value 1138 1141	29%
T64	value 1124 1127	37%
T65	population 269 276	subject
T21	pharmacokinetics 829 845	urinary recovery
T22	pharmacokinetics 463 479	urinary recovery
T66	interaction 578 584	little
T67	population 936 951	nonfasted group
T35	pharmacokinetics 314 331	Serum drug levels
